Menu
Back to User profile » Dr John Sheppard Jnr
Papers published by Dr John Sheppard Jnr:
Reproxalap Improves Signs and Symptoms of Allergic Conjunctivitis in an Allergen Chamber: A Real-World Model of Allergen Exposure
Clark D, Karpecki P, Salapatek AM, Sheppard JD, Brady TC
Clinical Ophthalmology 2022, 16:15-23
Published Date: 4 January 2022
Phase 3 Efficacy (Worse-Eye Analysis) and Long-Term Safety Evaluation of OTX-101 in Patients with Keratoconjunctivitis Sicca
Sheppard J, Bergmann M, Schechter BA, Luchs J, Ogundele A, Karpecki P
Clinical Ophthalmology 2021, 15:129-140
Published Date: 12 January 2021
Real world use of loteprednol etabonate ophthalmic gel 0.5% in cases representative of comorbid pathologies responding to minimally invasive glaucoma surgery
Sheppard JD, Singh IP
Clinical Ophthalmology 2019, 13:1279-1288
Published Date: 18 July 2019
A phase 2 randomized, double-masked, placebo-controlled study of novel nonsystemic kinase inhibitor TOP1630 for the treatment of dry eye disease
Taylor M, Ousler G, Torkildsen G, Walshe C, Fyfe MCT, Rowley A, Webber S, Sheppard JD, Duggal A
Clinical Ophthalmology 2019, 13:261-275
Published Date: 12 February 2019
Topical bromfenac for prevention and treatment of cystoid macular edema following cataract surgery: a review
Sheppard JD
Clinical Ophthalmology 2016, 10:2099-2111
Published Date: 25 October 2016
An update on the surgical management of pterygium and the role of loteprednol etabonate ointment
Sheppard JD, Mansur A, Comstock TL, Hovanesian JA
Clinical Ophthalmology 2014, 8:1105-1118
Published Date: 13 June 2014